Tylosin market to reach $1 billion by 2030 at 4.9% CAGR, driven by rising meat production and modernization of livestock farming practices.
Read MoreGlobal Ophthalmology Medical Service market size is expected to reach $65.9 by 2030 at 6%, rise in screen time driving growth of the market due to increasing pediatric eye conditions
Read MoreTumor necrosis factor inhibitor drugs market to reach $48.58 billion by 2030 at 2.8% CAGR, driven by increasing prevalence of autoimmune disorders worldwide.
Read MoreOphthalmology contract research organization market to reach $4.39 billion by 2030 at 8.1% cagr, driven by rising prevalence of eye disorders.
Read MoreTumor models market to reach $3.57 billion by 2030 at 10.8% CAGR, driven by growing demand for personalized medicine and tailored cancer treatment testing.
Read MoreTumor infiltrating lymphocytes market to reach $23.25 billion by 2030 at 14.0% CAGR, driven by rising number of cancer patients increasing demand for immunotherapies.
Read MoreTubulin inhibitors for breast cancer market to reach $2.78 billion by 2030 at 7.4% CAGR, driven by growing prevalence of chronic diseases including breast cancer.
Read MoreGlobal Ophthalmic Surgical Instruments market size is expected to reach $15.26 billion by 2030 at 6.1%, increasing incidence of eye diseases driving growth in the market
Read MoreOperating Tables market size is expected to reach $1.32 billion by 2030 at 5.1%, driven by increasing number of surgical procedures.
Read MoreTuberous sclerosis drug market to reach $1.26 billion by 2030 at 8.1% CAGR, driven by rising incidence of chronic diseases requiring long term disease management.
Read More